{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-archiving-and-retention-multi-region-rules”
},
“headline”: “SOP for TMF Archiving and Retention (Multi-Region Rules)”,
“description”: “This SOP defines standardized processes for archiving and retaining Trial Master Files (TMF/eTMF) in compliance with multi-regional requirements including FDA, EMA, CDSCO, and WHO, covering secure storage, retention timelines, access, retrieval, and inspection readiness.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 24/12/2025
Standard Operating Procedure for TMF Archiving and Retention (Multi-Region Rules)
| SOP No. | CR/OPS/080/2025 |
| Supersedes | NA |
| Page No. | 1 of 38 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to establish standardized processes for archiving and retaining Trial Master Files (TMF/eTMF) in compliance with multi-regional requirements. Proper
Scope
This SOP applies to all clinical trials conducted by the sponsor or through CROs where TMF/eTMF archiving and retention obligations exist. It covers procedures for indexing, secure storage, environmental controls, access, retrieval, and compliance with country-specific retention rules.
Responsibilities
- Sponsor: Ensures TMF/eTMF is archived and retained according to regulatory requirements.
- TMF Administrator: Manages indexing, secure storage, and retrieval processes.
- QA: Audits archived TMFs for integrity, security, and accessibility.
- IT/System Administrator: Manages eTMF backup, disaster recovery, and electronic archiving compliance.
- Vendors/Archivists: Ensure external archiving facilities meet regulatory standards.
Accountability
The sponsor is accountable for ensuring TMF/eTMF archiving complies with regional rules. TMF administrators and archivists are accountable for maintaining document security and accessibility. QA ensures independent verification.
Procedure
1. TMF Finalization
1.1 Perform final reconciliation of TMF/ISF before archiving.
1.2 Complete TMF Archiving Checklist (Annexure-1).
1.3 Ensure placeholders are resolved and QC checks completed.
2. Indexing and Preparation
2.1 Assign unique archive ID to each TMF.
2.2 Prepare TMF Archive Inventory Log (Annexure-2).
2.3 For eTMF, lock database, generate audit trail, and prepare read-only archive version.
3. Archiving Facilities
3.1 Store paper TMFs in controlled facilities with temperature 18–25°C and humidity 30–60%.
3.2 Facilities must have restricted access, fire protection, and disaster recovery systems.
3.3 For eTMFs, archive in validated systems with backup at separate geographic location.
4. Access and Retrieval
4.1 Access must be restricted to authorized personnel.
4.2 Maintain Archive Access Log (Annexure-3).
4.3 Retrieval requests must be documented and justified.
5. Retention Timelines (Examples)
5.1 FDA (21 CFR 312.57): 2 years after NDA approval or discontinuation.
5.2 EMA (Directive 2005/28/EC): 25 years for essential documents.
5.3 MHRA: Minimum 25 years.
5.4 CDSCO: Minimum 15 years.
5.5 WHO: Minimum 15 years or per product-specific requirements.
6. Transfer or Migration
6.1 Document any TMF transfer between facilities or vendors.
6.2 For eTMF migration, validate system transfer and reconcile documents.
6.3 Record details in TMF Transfer Log (Annexure-4).
7. Monitoring and Audit
7.1 QA audits archived TMFs annually for security and integrity.
7.2 Archive vendors must be qualified and re-qualified every 3 years.
Abbreviations
- SOP: Standard Operating Procedure
- TMF/eTMF: Trial Master File / electronic Trial Master File
- QA: Quality Assurance
- ISF: Investigator Site File
- NDA: New Drug Application
- FDA: Food and Drug Administration
- EMA: European Medicines Agency
- MHRA: Medicines and Healthcare products Regulatory Agency
- CDSCO: Central Drugs Standard Control Organization
- WHO: World Health Organization
Documents
- TMF Archiving Checklist (Annexure-1)
- TMF Archive Inventory Log (Annexure-2)
- Archive Access Log (Annexure-3)
- TMF Transfer Log (Annexure-4)
References
- ICH E6(R2/R3) – Section 8 Essential Documents
- FDA – Record Retention Requirements
- EMA – Archiving Guidance
- CDSCO – Record Retention Requirements
- WHO – Essential Document Archiving
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, TMF Administrator |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Quality |
Annexures
Annexure-1: TMF Archiving Checklist
| Item | Status | Remarks |
|---|---|---|
| TMF Reconciled | Yes | All documents verified |
| QC Performed | Yes | 100% check completed |
Annexure-2: TMF Archive Inventory Log
| Archive ID | Trial ID | Documents Included | Location |
|---|---|---|---|
| ARCH-2025-01 | CT-2025-001 | Full TMF | Archive Facility – Pune |
Annexure-3: Archive Access Log
| Date | User | Reason for Access | Approved By |
|---|---|---|---|
| 15/10/2025 | QA Auditor | Annual audit | QA Manager |
Annexure-4: TMF Transfer Log
| Date | Transferred From | Transferred To | Responsible | Remarks |
|---|---|---|---|---|
| 20/11/2025 | Vendor A | Vendor B | TMF Admin | System migration validated |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Quality |
For more SOPs visit: Pharma SOP
